Call Options Transactions Made in Q4 2023 in Revance Therapeutics, Inc. (RVNC)
This table provides information about the institutional ownership of Revance Therapeutics, Inc. (RVNC) during Q4 2023. The information is specifically focused on institutions that hold call options of Revance Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
256K+ 275.35% |
$1.49M - $2.86M
|
349K
$896K
|
|
Feb 14, 2024
Q4 2023
|
Centiva Capital, LP
New York, NY |
BUY
|
CALL |
200K+ 400.0% |
$1.16M - $2.24M
|
250K
$643K
|
|
Feb 14, 2024
Q4 2023
|
Ubs Oconnor LLC
Chicago, IL |
BUY
|
CALL |
55KNew |
$320K - $616K
|
55K
$141K
|
|
Feb 09, 2024
Q4 2023
|
Citigroup Inc
|
BUY
|
CALL |
42.3K+ 22.89% |
$246K - $474K
|
227K
$584K
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
38K+ 29.3% |
$221K - $426K
|
168K
$431K
|
|
Feb 14, 2024
Q4 2023
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
20.3K+ 6.58% |
$118K - $227K
|
329K
$845K
|
|
Feb 14, 2024
Q4 2023
|
Hunting Hill Global Capital, LLC
New York, NY |
BUY
|
CALL |
18.7K+ 69.52% |
$109K - $209K
|
45.6K
$117K
|
|
Feb 14, 2024
Q4 2023
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
CALL |
18.6K+ 364.71% |
$108K - $208K
|
23.7K
$60.9K
|
|
Feb 14, 2024
Q4 2023
|
Walleye Trading LLC
Plymouth, MN |
BUY
|
CALL |
18.4K+ 232.91% |
$107K - $206K
|
26.3K
$67.6K
|
|
Feb 14, 2024
Q4 2023
|
Capital Fund Management S.A.
Paris, I0 |
BUY
|
CALL |
3.2K+ 7.64% |
$18.6K - $35.8K
|
45.1K
$116K
|
|
Feb 14, 2024
Q4 2023
|
Gts Securities LLC
New York, NY |
BUY
|
CALL |
1K+ 7.14% |
$5.81K - $11.2K
|
15K
$38.6K
|
|
Feb 14, 2024
Q4 2023
|
Wolverine Trading, LLC
Chicago, IL |
SELL
|
CALL |
-1.3K- 7.6% |
$7.55K - $14.6K
|
15.8K
$40.6K
|
|
Feb 14, 2024
Q4 2023
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
CALL |
-6.6K- 29.33% |
$38.3K - $73.9K
|
15.9K
$40.9K
|